Effectiveness of Nationwide COPD Pay-for-Performance Program on COPD Exacerbations in Taiwan
Open Access
- 1 October 2021
- journal article
- research article
- Published by Taylor & Francis in International Journal of Chronic Obstructive Pulmonary Disease
- Vol. ume 16, 2869-2881
Abstract
Background: Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality worldwide. It has also imposed a substantial economic and social burden on the health care system. In Taiwan, a nationwide COPD pay-for-performance (P4P) program was designed to improve the quality of COPD-related care by introducing financial incentives for health care providers and employing a multidisciplinary team to deliver guideline-based, integrated care for patients with COPD, reducing adverse outcomes, especially COPD exacerbation. However, the results of a survey of the effectiveness of the pay-for-performance program in COPD management were inconclusive. To address this knowledge gap, this study evaluated the effectiveness of the COPD P4P program in Taiwan. Methods: This retrospective cohort study used data from Taiwan’s National Health Insurance claims database and nationwide COPD P4P enrollment program records from June 2016 to December 2018. Patients with COPD were classified into P4P and non-P4P groups. Patients in the P4P group were matched at a ratio of 1:1 based on age, gender, region, accreditation level, Charlson Comorbidity Index (CCI), and inhaled medication prescription type to create the non-P4P group. A difference-in-difference analysis was used to evaluate the influence of the P4P program on the likelihood of COPD exacerbation, namely COPD-related emergency department (ED) visit, intensive care unit (ICU) admission, or hospitalization. Results: The final sample of 14,288 patients comprised 7144 in each of the P4P and non-P4P groups. The prevalence of COPD-related ED visits, ICU admissions, and hospitalizations was higher in the P4P group than in the non-P4P group 1 year before enrollment. After enrollment, the P4P group exhibited a greater decrease in the prevalence of COPD-related ED visits and hospitalizations than the non-P4P group (ED visit: − 2.98%, p< 0.05, 95% confidence interval [CI]: − 0.277 to − 0.086; hospitalization: − 1.62%, p< 0.05, 95% CI: − 0.232 to − 0.020), whereas no significant difference was observed between the groups in terms of the changes in the prevalence of COPD-related ICU admissions. Conclusion: The COPD P4P program exerted a positive net effect on reducing the likelihood of COPD exacerbation, namely COPD-related ED visits and hospitalizations. Future studies should examine the long-term cost-effectiveness of the COPD P4P program.Keywords
This publication has 55 references indexed in Scilit:
- Pay for Performance: What We Measure MattersAMA Journal of Ethics, 2013
- The Potential for Cost Savings through Bundled Episode PaymentsNew England Journal of Medicine, 2012
- A Longitudinal Examination of a Pay-for-Performance Program for Diabetes CareMedical Care, 2012
- Pay-for-performance in disease management: a systematic review of the literatureBMC Health Services Research, 2011
- How can we improve guideline use? A conceptual framework of implementabilityImplementation Science, 2011
- The Unintended Consequence of Diabetes Mellitus Pay‐for‐Performance (P4P) Program in Taiwan: Are Patients with More Comorbidities or More Severe Conditions Likely to Be Excluded from the P4P Program?Health Services Research, 2010
- Has pay for performance improved the management of diabetes in the United Kingdom?Primary Care Diabetes, 2010
- Cost analysis of chronic obstructive pulmonary disease in a tertiary care setting in TaiwanRespirology, 2008
- Systematic Review of the Chronic Care Model in Chronic Obstructive Pulmonary Disease Prevention and ManagementArchives of internal medicine (1960), 2007
- Care Patterns in Medicare and Their Implications for Pay for PerformanceNew England Journal of Medicine, 2007